NCT00432432View on ClinicalTrials.gov

Combination Methotrexate and Infliximab

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

October 31, 2006

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Infliximab and MTX

MTX 15mg weekly Infliximab 5mg/kg given at day 0, wk 2, wk6

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00432432 - Combination Methotrexate and Infliximab | Biotech Hunter | Biotech Hunter